Personalized Medicine in the Age of Pharmacoproteomics: A Close up on India and Need for Social Science Engagement for Responsible Innovation in Post-Proteomic Biology.

“Because DNA sequencing technology is inherently simpler and more scalable than protein analytical technology, and because the finiteness of genomes invited a spirit of rapid conquest, the notion of genome sequencing has displaced that of protein databases in the minds of most molecular biologists for the last decade…As proteomics now takes center stage in molecular biology, it is appropriate to take stock of progress to date and consider the major strategic objectives that can be achieved during the next stages of its evolution”.

[1]  Harvey B Pollard,et al.  Pharmacoproteomics of 4-phenylbutyrate-treated IB3-1 cystic fibrosis bronchial epithelial cells. , 2006, Journal of proteome research.

[2]  V. S. Reddy,et al.  Proteome analysis reveals a large merozoite surface protein-1 associated complex on the Plasmodium falciparum merozoite surface. , 2011, Journal of proteome research.

[3]  G. Böhme,et al.  The Knowledge Society , 1986 .

[4]  Xiao-yong Lei,et al.  Anti-apoptotic Effects of Probucol are Associated with Downregulation of Daxx Expression in THP-1 Macrophage , 2007, Cardiovascular Drugs and Therapy.

[5]  Winston Haynes,et al.  SPIRE: Systematic protein investigative research environment. , 2011, Journal of proteomics.

[6]  David H. Guston,et al.  Innovation policy: not just a jumbo shrimp , 2008, Nature.

[7]  Jean Armengaud,et al.  Proteogenomics and systems biology: quest for the ultimate missing parts , 2010, Expert review of proteomics.

[8]  Soo-Ik Chang,et al.  Pharmacoproteomic Analysis of a Novel Cell-permeable Peptide Inhibitor of Tumor-induced Angiogenesis* , 2011, Molecular & Cellular Proteomics.

[9]  Vural Ozdemir,et al.  Asia-Pacific Health 2020 and Genomics without Borders: Co-Production of Knowledge by Science and Society Partnership for Global Personalized Medicine. , 2011, Current pharmacogenomics and personalized medicine.

[10]  Se-Hui Jung,et al.  Rapid determination of blood coagulation factor XIII activity using protein arrays for serodiagnosis of human plasma. , 2011, Analytical chemistry.

[11]  Yann Joly,et al.  Forward Look: Tenth Anniversary of the Human Genome Sequence and 21 Century Postgenomics Global Health - A Close Up on Africa and Women's Health. , 2011, Current pharmacogenomics and personalized medicine.

[12]  Sanjeeva Srivastava,et al.  Protein microarrays and novel detection platforms , 2011, Expert review of proteomics.

[13]  C. Mitcham,et al.  Midstream Modulation of Technology: Governance From Within , 2006 .

[14]  Bartha M Knoppers,et al.  Steering vaccinomics innovations with anticipatory governance and participatory foresight. , 2011, Omics : a journal of integrative biology.

[15]  Cathy H. Wu,et al.  The Human Proteome Project: Current State and Future Direction , 2011, Molecular & Cellular Proteomics.

[16]  R. Shukla,et al.  Proteomics indicates modulation of tubulin polymerization by L‐menthol inhibiting human epithelial colorectal adenocarcinoma cell proliferation , 2011, Proteomics.

[17]  Jean Kyung Paik,et al.  Influence of Adiponectin Gene Polymorphisms on Adiponectin Level and Insulin Resistance Index in Response to Dietary Intervention in Overweight-Obese Patients With Impaired Fasting Glucose or Newly Diagnosed Type 2 Diabetes , 2009, Diabetes Care.

[18]  Utpal Tatu,et al.  A glimpse into the clinical proteome of human malaria parasites Plasmodium falciparum and Plasmodium vivax , 2009, Proteomics. Clinical applications.

[19]  Brian Wynne,et al.  Public Engagement as a Means of Restoring Public Trust in Science – Hitting the Notes, but Missing the Music? , 2006, Public Health Genomics.

[20]  O. Corrigan,et al.  Personalized Medicine in a Consumer Age , 2011 .

[21]  B K Tang,et al.  The science of pharmacological variability: An essay , 1999, Clinical pharmacology and therapeutics.

[22]  Pradhyumna K. Singh,et al.  2‐D gel electrophoresis‐based proteomic analysis reveals that ormeloxifen induces G0–G1 growth arrest and ERK‐mediated apoptosis in chronic myeloid leukemia cells K562 , 2011, Proteomics.

[23]  Akihiko Yoshida,et al.  Secernin-1 as a novel prognostic biomarker candidate of synovial sarcoma revealed by proteomics. , 2011, Journal of proteomics.

[24]  Ravi Sirdeshmukh,et al.  Proteomic and Transcriptomic Analysis of Aspergillus fumigatus on Exposure to Amphotericin B , 2008, Antimicrobial Agents and Chemotherapy.

[25]  Maria Kavallaris,et al.  Proteomic analysis reveals a novel role for the actin cytoskeleton in vincristine resistant childhood leukemia – An in vivo study , 2006, Proteomics.

[26]  Pascale Lehoux,et al.  Editorial (Moving Beyond Our Mutual Ignorance. Or, How would Engaging the Public Benefit the Personalized Medicine Community?) , 2011 .

[27]  N G Anderson,et al.  Back to the future: The human protein index (HPI) and the agenda for post‐proteomic biology , 2001, Proteomics.

[28]  Akhilesh Pandey,et al.  A comprehensive map of the human urinary proteome. , 2011, Journal of proteome research.

[29]  I. Kickbusch,et al.  Tackling the political determinants of global health , 2005, BMJ : British Medical Journal.

[30]  Choon-Sik Park,et al.  Application of proteomics in asthma research , 2011, Expert review of proteomics.

[31]  Michael Gibbons,et al.  Introduction: `Mode 2' Revisited: The New Production of Knowledge , 2003 .

[32]  Kumaran Kandasamy,et al.  SILAC-based quantitative proteomic approach to identify potential biomarkers from the esophageal squamous cell carcinoma secretome , 2010, Cancer biology & therapy.

[33]  Sadhana Kannan,et al.  Proteomic profiling of cancer of the gingivo‐buccal complex: Identification of new differentially expressed markers , 2009, Proteomics. Clinical applications.

[34]  Min-Seok Kwon,et al.  Overview and introduction to clinical proteomics. , 2008, Methods in molecular biology.

[35]  Eugene Kolker,et al.  Risk assessment and communication tools for genotype associations with multifactorial phenotypes: the concept of "edge effect" and cultivating an ethical bridge between omics innovations and society. , 2009, Omics : a journal of integrative biology.

[36]  S. Schreiber,et al.  Printing proteins as microarrays for high-throughput function determination. , 2000, Science.

[37]  Surendra Dasari,et al.  Proteomic identification of salivary biomarkers of type-2 diabetes. , 2009, Journal of proteome research.

[38]  I. Kickbusch,et al.  The Leavell Lecture 1 -The end of Public Health as we Know it: Constructing Global Public Health in the 21st Century , 2004 .

[39]  E. Diamandis,et al.  The bottleneck in the cancer biomarker pipeline and protein quantification through mass spectrometry-based approaches: current strategies for candidate verification. , 2010, Clinical chemistry.

[40]  Anuradha Dube,et al.  Proteomic approach for identification and characterization of novel immunostimulatory proteins from soluble antigens of Leishmania donovani promastigotes , 2007, Proteomics.

[41]  Bartha M Knoppers,et al.  Nutriproteomics and Proteogenomics: Cultivating Two Novel Hybrid Fields of Personalized Medicine with Added Societal Value. , 2010, Current pharmacogenomics and personalized medicine.

[42]  Chi Bun Ching,et al.  VKORC1 Pharmacogenetics and Pharmacoproteomics in Patients on Warfarin Anticoagulant Therapy: Transthyretin Precursor as a Potential Biomarker , 2010, PloS one.

[43]  Abdallah S Daar.  Chronic Non-communicable Diseases as a Threat for All: Recent Global Initiatives. , 2010, Sultan Qaboos University medical journal.

[44]  P. R. Deepa,et al.  Comparative proteomic analysis of differentially expressed proteins in primary retinoblastoma tumors , 2010, Proteomics. Clinical applications.

[45]  N. Oudshoorn,et al.  How Users Matter: The Co-Construction of Users and Technology (Inside Technology) , 2003 .

[46]  Terence C W Poon,et al.  Pharmacoproteomics study of cetuximab in nasopharyngeal carcinoma. , 2006, Journal of proteome research.

[47]  Vani Santosh,et al.  Differential protein expression in human gliomas and molecular insights , 2005, Proteomics.

[48]  Vani Santosh,et al.  Proteomic identification of haptoglobin α2 as a glioblastoma serum biomarker: implications in cancer cell migration and tumor growth. , 2010, Journal of proteome research.

[49]  Mehdi Mesri,et al.  Realizing individualized medicine: the road to translating proteomics from the laboratory to the clinic. , 2011, Personalized medicine.